Literature DB >> 3871082

Low-level exercise testing after myocardial infarction: usefulness in enhancing clinical risk stratification.

R J Krone, J A Gillespie, F M Weld, J P Miller, A J Moss.   

Abstract

Of 866 patients enrolled in our multicenter study, 667 performed a low-level exercise test early after myocardial infarction, most before discharge. Excluding seven patients who died before the test could be considered, there was a 14% 1 year cardiac mortality in 192 patients who did not take the test (150 for medical and 42 for logistic reasons) compared with 5% in those who did (p less than .0001). Of those who took the test, 12% subsequently underwent bypass grafts surgery compared with 14% of those who did not (p greater than .05). Decreased mortality in the year after the infarction in those taking the test was associated with an increase in blood pressure to 110 mm Hg or higher (3% vs 18%; p less than .001), ability to complete the 9 min test (3% vs 8%; p less than .01), and the absence of couplets (4% vs 13%; p less than .05) or any ventricular ectopic depolarizations (4% vs 7%, p less than .05) before, during, or after exercise. Achievement of a blood pressure of 110 mm Hg or higher during exercise in patients with no evidence of pulmonary congestion on the chest x-ray identified a group of 454 patients (70% of those taking the test) with a 1 year cardiac mortality of 1% compared with 13% in the remaining patients (p less than .0001). Logistic models showed that the exercise test contributed independent prognostic information for cardiac death, new infarction, and bypass surgery. Results of low-level exercise testing before hospital discharge combined with clinical features of the infarction can effectively identify patients at low risk for subsequent cardiac mortality.

Entities:  

Mesh:

Year:  1985        PMID: 3871082     DOI: 10.1161/01.cir.71.1.80

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  14 in total

Review 1.  Peptide synthesis through evolution.

Authors:  K Tamura; R W Alexander
Journal:  Cell Mol Life Sci       Date:  2004-06       Impact factor: 9.261

Review 2.  Role of nuclear cardiac imaging in myocardial infarction: postinfarction risk stratification.

Authors:  John J Mahmarian; Girish Dwivedi; Tultul Lahiri
Journal:  J Nucl Cardiol       Date:  2004 Mar-Apr       Impact factor: 5.952

Review 3.  [Complications during exercise testing].

Authors:  R Berent; J Auer; S P von Duvillard; H Sinzinger; P Schmid
Journal:  Herz       Date:  2011-11-17       Impact factor: 1.443

Review 4.  Non-invasive risk stratification: prognostic implications of exercise testing.

Authors:  C W Israel
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2007-03

5.  The VANQWISH Trial: support for the noninvasive strategy for risk stratification after acute myocardial infarction.

Authors:  G A Beller; K A Brown
Journal:  J Nucl Cardiol       Date:  1998 Nov-Dec       Impact factor: 5.952

6.  Predicting severe ischemic events after uncomplicated myocardial infarction by exercise testing and rest and exercise radionuclide ventriculography.

Authors:  G Mazzotta; A Camerini; G Scopinarô; G Villavecchiâ; R Lionetto; C Vecchio
Journal:  J Nucl Cardiol       Date:  1994 May-Jun       Impact factor: 5.952

Review 7.  Stratifying risk after a myocardial infarction.

Authors:  N F Goldschlager
Journal:  West J Med       Date:  1988-07

8.  Prognostic significance of exercise-induced premature ventricular complexes: a systematic review and meta-analysis of observational studies.

Authors:  Victor Lee; Dhanuka Perera; Pier Lambiase
Journal:  Heart Asia       Date:  2017-01-04

9.  Post-myocardial infarction risk stratification.

Authors:  D A Meldrum
Journal:  Can Fam Physician       Date:  1987-04       Impact factor: 3.275

10.  Limitations on the prognostic value of predischarge data after myocardial infarction.

Authors:  H Cleempoel; H Vainsel; M Dramaix; A Lenaers; E Contu; M Hoylaerts; B Demaret; M de Marneffe; J L Vandenbossche; M Renard
Journal:  Br Heart J       Date:  1988-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.